What is the most appropriate initial screening test for gestational diabetes in a 22-week pregnant woman with a family history of Diabetes Mellitus (DM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Screening for Gestational Diabetes in a 22-Week Pregnant Woman with Family History of Diabetes

This patient should undergo a 75g oral glucose tolerance test (OGTT) at 24-28 weeks of gestation, which is the standard screening window for all pregnant women, including those with a family history of diabetes. 1, 2

Risk Assessment and Timing

This 22-week pregnant woman with a family history of diabetes (mother with DM) falls into the average-risk category for gestational diabetes mellitus (GDM), not high-risk, based on current guidelines. 1

High-risk criteria requiring immediate screening include:

  • Marked obesity (BMI ≥30 kg/m²)
  • Personal history of previous GDM
  • Glycosuria detected on urinalysis
  • Strong family history of diabetes (first-degree relative)

1, 2

Since BMI was not mentioned and she has no other high-risk features beyond family history, she does not meet criteria for early screening at 22 weeks. 2

Recommended Screening Approach

At 24-28 weeks gestation, perform one of the following:

Option 1: One-Step Approach (75g OGTT) - Preferred

  • Perform a 75g OGTT with fasting, 1-hour, and 2-hour glucose measurements
  • Diagnostic thresholds (any ONE value diagnostic):
    • Fasting: ≥92 mg/dL (5.1 mmol/L)
    • 1-hour: ≥180 mg/dL (10.0 mmol/L)
    • 2-hour: ≥153 mg/dL (8.5 mmol/L)

1, 2

Option 2: Two-Step Approach (Alternative)

  • Step 1: 50g glucose challenge test (non-fasting) with 1-hour glucose measurement
  • Step 2: If ≥140 mg/dL (or ≥130-135 mg/dL in high-risk populations), proceed to 100g OGTT
  • 100g OGTT diagnostic thresholds (TWO or more values required):
    • Fasting: ≥95 mg/dL (5.3 mmol/L)
    • 1-hour: ≥180 mg/dL (10.0 mmol/L)
    • 2-hour: ≥155 mg/dL (8.6 mmol/L)
    • 3-hour: ≥140 mg/dL (7.8 mmol/L)

1, 2, 3

Why NOT the Other Options

Fasting glucose now (at 22 weeks): Not recommended as a standalone screening test at this gestational age. Fasting glucose is only used for early screening in high-risk women at first prenatal visit (12-14 weeks), and this patient doesn't meet high-risk criteria. 1, 2

HbA1c now: Not recommended for GDM screening during pregnancy. HbA1c is only useful for detecting pre-existing overt diabetes in early pregnancy (before 20 weeks) in high-risk women, not for GDM screening. 1, 4

The 3-hour OGTT at 24-28 weeks: This is the 100g OGTT used in the two-step approach, but it's only performed AFTER a positive 50g glucose challenge test, not as the initial screening test. 1, 3

Important Clinical Considerations

The 75g OGTT (one-step approach) has several advantages:

  • Faster diagnosis with single test
  • Better patient tolerance
  • Outcome-based criteria from the HAPO study
  • Simpler to execute and remember
  • More aligned with international consensus

1, 5, 6

Common pitfall to avoid: Do not perform early screening (before 24 weeks) in average-risk women, as there is insufficient evidence for benefit and it may lead to overdiagnosis and unnecessary interventions. 7, 3

If this patient had BMI ≥30 kg/m² or previous GDM: She would require screening at first prenatal visit AND repeat screening at 24-28 weeks if initially negative. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Screening for Gestational Diabetes in Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Gestational Diabetes Screening and Management at 24 Weeks of Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Gestational diabetes mellitus (Update 2023)].

Wiener klinische Wochenschrift, 2023

Research

Screening and Diagnosis of Gestational Diabetes Mellitus, Where Do We Stand.

Journal of clinical and diagnostic research : JCDR, 2016

Guideline

Gestational Diabetes Screening at 21 Weeks for Travel Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.